Riverbridge Partners’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $209K | Sell |
|
|||||
|
2023
Q2 | $143M | Buy |
|
|||||
|
2023
Q1 | $112M | Sell |
|
|||||
|
2022
Q4 | $127M | Sell |
|
|||||
|
2022
Q3 | $158M | Buy |
|
|||||
|
2022
Q2 | $158M | Sell |
|
|||||
|
2022
Q1 | $292M | Buy |
|
|||||
|
2021
Q4 | $257M | Buy |
|
|||||
|
2021
Q3 | $151M | Sell |
|
|||||
|
2021
Q2 | $249M | Buy |
|
|||||
|
2021
Q1 | $243M | Buy |
|
|||||
|
2020
Q4 | $217M | Buy |
|
|||||
|
2020
Q3 | $164M | Buy |
|
|||||
|
2020
Q2 | $133M | Buy |
|
|||||
|
2020
Q1 | $121M | Sell |
|
|||||
|
2019
Q4 | $111M | Sell |
|
|||||
|
2019
Q3 | $87.6M | Buy |
|
|||||
|
2019
Q2 | $80.5M | Buy |
|